Many recent human studies have found positive associations between chemerin and markers of obesity, inflammation and measures of metabolic syndrome indicating that chemerin concentrations are modifiable in obesity and may contribute to human diseases associated with obesity or inflammation [10], [11], [12], [26], [76]. This evidence concerns the gene RARRES2 and obesity disorder.